TP53 and ovarian carcinoma: Therefore, p53, STAT3, and RAS may inhibit or promote ovarian cancer cell tumor growth, metastasis, and chemoresistance through the differential regulation of the MAPK- and PI3K/AKT-mediated ERS and autophagy.